Generate Biomedicines Inc (GENB)

Over the past 90 days, Generate Biomedicines Inc. recorded five insider trading transactions, all involving sales by director Frances Arnold totaling approximately $922,100. These divestments occurred amid a 23.1% decline in stock value. The company's most recent earnings report showed a 24.38% miss on earnings per share expectations.
Ticker: GENB Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Generate Biomedicines Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
ARNOLD FRANCES Non-Executive Director
Transaction date
Planned sale
Price
196.34
Quantity 6,133 +30.0%
Value US$664,709
3.2
ARNOLD FRANCES Director Non-Executive Director
Transaction date
Proposed sale
Price
481.63
Quantity 27,495
Value US$410,113
3.2
ARNOLD FRANCES Director Non-Executive Director
Transaction date
Proposed sale
Price
252.62
Quantity 37,676
Value US$735,426
3.2
ARNOLD FRANCES Non-Executive Director
Transaction date
Planned sale
Price
16.00
Quantity 1,000 -0.4%
Value US$16,002
3.2
ARNOLD FRANCES Director Non-Executive Director
Transaction date
Proposed sale
Price
16.00
Quantity 1,000
Value US$16,002
2.4
Nally Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
12.00
Quantity 20,000 +3.6%
Value US$240,000
Grous Beth Chief People Officer Officer
Transaction date
Purchase
Price
16.00
Quantity 300 New position
Value US$4,800
Silvers Jason President & CFO Officer
Transaction date
Purchase
Price
16.00
Quantity 1,000 New position
Value US$16,000
Silvers Jason President & CFO Officer
Transaction date
Purchase
Price
16.00
Quantity 500 New position
Value US$8,000
Silvers Jason President & CFO Officer
Transaction date
Purchase
Price
16.00
Quantity 500 New position
Value US$8,000
3.4
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 New position
Value US$25,000,000
3.4
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +56.3%
Value US$25,000,000
3.4
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +11.4%
Value US$25,000,000
Mendillo Jane L Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 1,500 New position
Value US$24,000
3.4
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 New position
Value US$25,000,000
3.4
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +56.3%
Value US$25,000,000
3.4
AFEYAN NOUBAR Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 1,562,500 +11.4%
Value US$25,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-04 2026-10-29 PlS Planned sale Non-Executive Director
6,133 +30.0%
196.34
US$664,709
6,133 +30.0% 196.34 US$664,709
2026-10-29 2026-10-29 PrS Proposed sale

Director

Non-Executive Director
27,495
481.63
US$410,113
27,495 481.63 US$410,113
2026-09-02 2026-09-02 PrS Proposed sale

Director

Non-Executive Director
37,676
252.62
US$735,426
37,676 252.62 US$735,426
2026-09-03 2026-09-01 PlS Planned sale Non-Executive Director
1,000 -0.4%
16.00
US$16,002
1,000 -0.4% 16.00 US$16,002
2026-09-01 2026-09-01 PrS Proposed sale

Director

Non-Executive Director
1,000
16.00
US$16,002
1,000 16.00 US$16,002
2026-03-06 2026-03-04 B Purchase

Chief Executive Officer

Executive Director
20,000 +3.6%
12.00
US$240,000
20,000 +3.6% 12.00 US$240,000
2026-03-02 2026-03-02 B Purchase

Chief People Officer

Officer
300 New position
16.00
US$4,800
300 New position 16.00 US$4,800
2026-03-02 2026-03-02 B Purchase

President & CFO

Officer
1,000 New position
16.00
US$16,000
1,000 New position 16.00 US$16,000
2026-03-02 2026-03-02 B Purchase

President & CFO

Officer
500 New position
16.00
US$8,000
500 New position 16.00 US$8,000
2026-03-02 2026-03-02 B Purchase

President & CFO

Officer
500 New position
16.00
US$8,000
500 New position 16.00 US$8,000
2026-03-02 2026-03-02 B Purchase Non-Executive Director Large shareholder
1,562,500 New position
16.00
US$25,000,000
1,562,500 New position 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase Non-Executive Director Large shareholder
1,562,500 +56.3%
16.00
US$25,000,000
1,562,500 +56.3% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase Non-Executive Director Large shareholder
1,562,500 +11.4%
16.00
US$25,000,000
1,562,500 +11.4% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase Non-Executive Director
1,500 New position
16.00
US$24,000
1,500 New position 16.00 US$24,000
2026-03-02 2026-03-02 B Purchase Non-Executive Director Large shareholder
1,562,500 New position
16.00
US$25,000,000
1,562,500 New position 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase Non-Executive Director Large shareholder
1,562,500 +56.3%
16.00
US$25,000,000
1,562,500 +56.3% 16.00 US$25,000,000
2026-03-02 2026-03-02 B Purchase Non-Executive Director Large shareholder
1,562,500 +11.4%
16.00
US$25,000,000
1,562,500 +11.4% 16.00 US$25,000,000